ATE524468T1 - Derivate aus n-phenyl-imidazo-(1,2-a)-pyridin-2- carboxamiden, ihre herstellung sowie ihre therapeutische anwendung - Google Patents

Derivate aus n-phenyl-imidazo-(1,2-a)-pyridin-2- carboxamiden, ihre herstellung sowie ihre therapeutische anwendung

Info

Publication number: ATE524468T1
Authority: AT; Austria
Prior art keywords: carboxamides; imidazo; pyridine; phenyl; derivatives
Prior art date: 2008-01-02

Application number

AT08872826T

Other languages

English (en)

Inventor

Jean-Francois Peyronel

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-01-02

Filing date

2008-12-31

Publication date

2011-09-15

2008-12-31 Application filed by Sanofi Sa filed Critical Sanofi Sa

2011-09-15 Application granted granted Critical

2011-09-15 Publication of ATE524468T1 publication Critical patent/ATE524468T1/de

Links

230000001225 therapeutic effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Psychology (AREA)
Addiction (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Transplantation (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Obesity (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT08872826T 2008-01-02 2008-12-31 Derivate aus n-phenyl-imidazo-(1,2-a)-pyridin-2- carboxamiden, ihre herstellung sowie ihre therapeutische anwendung ATE524468T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0800002A FR2925900B1 (fr)	2008-01-02	2008-01-02	DERIVES DE N-PHENYL-IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
PCT/FR2008/001833 WO2009106748A2 (fr)	2008-01-02	2008-12-31	Dérivés de n-phenyl-imidazo[1,2-a]pyridine-2-carboxamides, leur préparation et leur application en thérapeutique

Publications (1)

Publication Number	Publication Date
ATE524468T1 true ATE524468T1 (de)	2011-09-15

Family

ID=39691313

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT08872826T ATE524468T1 (de)	2008-01-02	2008-12-31	Derivate aus n-phenyl-imidazo-(1,2-a)-pyridin-2- carboxamiden, ihre herstellung sowie ihre therapeutische anwendung

Country Status (21)

Country	Link
US (1)	US20100317685A1 (de)
EP (1)	EP2225241B1 (de)
JP (1)	JP2011508758A (de)
KR (1)	KR20100099245A (de)
CN (1)	CN101910176A (de)
AR (1)	AR070071A1 (de)
AT (1)	ATE524468T1 (de)
AU (1)	AU2008351926A1 (de)
BR (1)	BRPI0821674A2 (de)
CA (1)	CA2710943A1 (de)
CL (1)	CL2008003926A1 (de)
CO (1)	CO6321243A2 (de)
EA (1)	EA201070816A1 (de)
FR (1)	FR2925900B1 (de)
IL (1)	IL206668A0 (de)
MA (1)	MA32060B1 (de)
MX (1)	MX2010007348A (de)
TW (1)	TW200942539A (de)
UY (1)	UY31586A1 (de)
WO (1)	WO2009106748A2 (de)
ZA (1)	ZA201004641B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2903108B1 (fr) *	2006-07-03	2008-08-29	Sanofi Aventis Sa	Utilisation de derives d'imidazo[1,2-a] pyridine-2-carboxamides en therapeutique.
FR2925906B1 (fr) *	2008-01-02	2010-08-20	Sanofi Aventis	COMPOSES DE N-PHENYL-IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2950344B1 (fr) *	2009-09-18	2011-11-25	Sanofi Aventis	Derives de 5-phenyl-pyrazolopyridine, leur preparation et leur aplication en therapeutique.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2638161B1 (fr) *	1988-10-24	1991-01-11	Centre Nat Rech Scient	Nouvelles benzoyl-2 imidazo (1,2-a) pyridines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
CA2545711A1 (en) *	2003-11-13	2005-06-02	Ambit Biosciences Corporation	Urea derivatives as kinase modulators
CA2589773A1 (en) *	2004-12-22	2006-06-29	Astrazeneca Ab	Pyridine carboxamide derivatives for use as anticancer agents
FR2903107B1 (fr) *	2006-07-03	2008-08-22	Sanofi Aventis Sa	Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
FR2903108B1 (fr) *	2006-07-03	2008-08-29	Sanofi Aventis Sa	Utilisation de derives d'imidazo[1,2-a] pyridine-2-carboxamides en therapeutique.
FR2925906B1 (fr) *	2008-01-02	2010-08-20	Sanofi Aventis	COMPOSES DE N-PHENYL-IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

2008
- 2008-01-02 FR FR0800002A patent/FR2925900B1/fr not_active Expired - Fee Related
- 2008-12-30 UY UY31586A patent/UY31586A1/es not_active Application Discontinuation
- 2008-12-30 CL CL2008003926A patent/CL2008003926A1/es unknown
- 2008-12-30 AR ARP080105776A patent/AR070071A1/es unknown
- 2008-12-31 CA CA2710943A patent/CA2710943A1/fr not_active Abandoned
- 2008-12-31 EA EA201070816A patent/EA201070816A1/ru unknown
- 2008-12-31 BR BRPI0821674-6A patent/BRPI0821674A2/pt not_active IP Right Cessation
- 2008-12-31 MX MX2010007348A patent/MX2010007348A/es active IP Right Grant
- 2008-12-31 EP EP08872826A patent/EP2225241B1/de active Active
- 2008-12-31 JP JP2010541082A patent/JP2011508758A/ja not_active Withdrawn
- 2008-12-31 AU AU2008351926A patent/AU2008351926A1/en not_active Abandoned
- 2008-12-31 KR KR1020107014641A patent/KR20100099245A/ko not_active Withdrawn
- 2008-12-31 AT AT08872826T patent/ATE524468T1/de not_active IP Right Cessation
- 2008-12-31 CN CN200880123840XA patent/CN101910176A/zh active Pending
- 2008-12-31 TW TW097151693A patent/TW200942539A/zh unknown
- 2008-12-31 WO PCT/FR2008/001833 patent/WO2009106748A2/fr not_active Ceased
2010
- 2010-06-28 IL IL206668A patent/IL206668A0/en unknown
- 2010-07-01 US US12/828,369 patent/US20100317685A1/en not_active Abandoned
- 2010-07-01 ZA ZA2010/04641A patent/ZA201004641B/en unknown
- 2010-07-02 CO CO10080881A patent/CO6321243A2/es not_active Application Discontinuation
- 2010-08-02 MA MA33058A patent/MA32060B1/fr unknown

Also Published As

Publication number	Publication date
EA201070816A1 (ru)	2010-12-30
FR2925900A1 (fr)	2009-07-03
CL2008003926A1 (es)	2010-02-12
UY31586A1 (es)	2009-08-03
IL206668A0 (en)	2010-12-30
EP2225241A2 (de)	2010-09-08
JP2011508758A (ja)	2011-03-17
CN101910176A (zh)	2010-12-08
WO2009106748A3 (fr)	2009-12-30
EP2225241B1 (de)	2011-09-14
CA2710943A1 (fr)	2009-09-03
KR20100099245A (ko)	2010-09-10
MA32060B1 (fr)	2011-02-01
MX2010007348A (es)	2010-08-18
BRPI0821674A2 (pt)	2015-06-16
WO2009106748A2 (fr)	2009-09-03
CO6321243A2 (es)	2011-09-20
ZA201004641B (en)	2011-09-28
FR2925900B1 (fr)	2011-03-04
TW200942539A (en)	2009-10-16
US20100317685A1 (en)	2010-12-16
AU2008351926A1 (en)	2009-09-03
AR070071A1 (es)	2010-03-10

Legal Events

Date	Code	Title	Description
2012-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE467633T1 (de)	2010-05-15	2-aryl-6-phenylimidazoä1,2-aüpyridin-derivate, ihre herstellung und therapeutische verwendung
ATE461930T1 (de)	2010-04-15	Harnstoffderivate von tropan, ihre herstellung und ihre therapeutische anwendung
ATE475661T1 (de)	2010-08-15	Triazolopyridin-carboxamid-derivate sowie ihre herstellung und therapeutische verwendung
HUS1600048I1 (hu)	2017-01-30	Készítmény Fabry-kór kezelésére
DE602005006815D1 (de)	2008-06-26	2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendung
ATE453637T1 (de)	2010-01-15	N-(aminoheteroaryl)-1h-indol-2-carboxamid- derivate sowie deren herstellung und therapeutische anwendung
ATE372998T1 (de)	2007-09-15	1-aminophthalazinderivate, deren herstellung und deren therapeutische verwendung
ATE548349T1 (de)	2012-03-15	In stellung 3 disubstituierte indol-2-on- pyridinderivate, ihre herstellung sowie ihre therapeutische anwendung
WO2009015037A3 (en)	2009-04-30	5-pyridinone substituted indazoles
ATE512970T1 (de)	2011-07-15	Dimere von artemisininderivaten, deren herstellung und deren therapeutische verwendung
ATE540023T1 (de)	2012-01-15	Neuartige 3-aminoalkyl-1,3-dihydro-2h-indol-2-on- derivate, ihre herstellung und therapeutische verwendung
ATE543822T1 (de)	2012-02-15	2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo ä1,2-ibü-pyridazinderivate, deren herstellung und deren therapeutische anwendung
ATE502035T1 (de)	2011-04-15	2-amido-4-phenylthiazol-derivate, ihre herstellung und ihre therapeutische verwendung
ATE531715T1 (de)	2011-11-15	1,3-dihydro-2h-pyrroloä3.2-büpyridin-2-onderiva e,deren herstellung und deren therapeutische verwendungen
ATE520654T1 (de)	2011-09-15	Polypyrrol-derivate, ihre herstellung und ihre therapeutische verwendung
DE602005019743D1 (de)	2010-04-15	Oxopiperidinderivate, ihre herstellung und therapeutische verwendung
IL199902A0 (en)	2010-04-15	Orotate antimetabolite derivatives, methods of producing the same and uses thereof
ATE512968T1 (de)	2011-07-15	1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6- carboxamid und 2,3,4,5-tetrahydropyrrolo(1,2-a)- diazepin-7-carboxamid- derivate, ihre herstellung und therapeutische verwendung
ATE499351T1 (de)	2011-03-15	Aryl- und heteroaryl-ethyl-acylguanidinderivate, ihre herstellung und ihre therapeutische anwendung
ATE529426T1 (de)	2011-11-15	N-phenyl-imidazo(1,2-a)pyridincarboxamid- verbindungen, ihre herstellung sowie ihre therapeutische anwendung
DE102008002364A8 (de)	2010-06-02	Ru-Sulfoxid-Komplexe, deren Herstellung und Verwendung
ATE423119T1 (de)	2009-03-15	Pyridoä2,3-düpyrimidin-derivate sowie deren herstellung und therapeutische anwendung
ATE524468T1 (de)	2011-09-15	Derivate aus n-phenyl-imidazo-(1,2-a)-pyridin-2- carboxamiden, ihre herstellung sowie ihre therapeutische anwendung
ATE542806T1 (de)	2012-02-15	Diarylmethylpiperazinderivate, deren herstellung und deren verwendung
EP1968616A4 (de)	2009-10-21	Sulindac-derivate, ihre verwendung und herstellung